Sanofi | CIK:0001121404 | 3

  • Filed: 3/16/2018
  • Entity registrant name: Sanofi (CIK: 0001121404)
  • Generator: Donnelley Financial Solutions
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/1121404/000119312518084834/0001193125-18-084834-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/1121404/000119312518084834/sny-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001121404
  • Open this page in separate window: Click
  • ifrs-full:DisclosureOfBusinessCombinationsExplanatory

    The provisional purchase price allocation resulted in the recognition of goodwill amounting to 125 million, as indicated below:

     

     

    ( million)   

    Fair value at

    acquisition date

     
    Other intangible assets      776  
    Inventories      4  
    Other assets and liabilities      (15)  
    Net deferred tax position      (259)  
    Net assets of Protein Sciences as of August 25, 2017      506  
    Goodwill      125  
    Purchase price      631